Test Description

What is a Serum Ethanol Level?

A serum ethanol level measures the concentration of ethyl alcohol in the blood. It provides an objective measure of alcohol exposure that can be correlated with clinical effects, though tolerance dramatically affects the relationship between level and impairment.

Pharmacokinetics

  • Absorption: Rapid from stomach (20%) and small intestine (80%); peak levels 30-90 minutes after ingestion on an empty stomach
  • Distribution: Distributes into total body water; volume of distribution approximately 0.6 L/kg
  • Metabolism: Primarily hepatic via alcohol dehydrogenase (ADH) to acetaldehyde, then via aldehyde dehydrogenase (ALDH) to acetate
  • Elimination: Zero-order kinetics — constant rate regardless of concentration (approximately 15-25 mg/dL/hour; chronic drinkers may metabolize faster at 25-35 mg/dL/hour)

Clinical Utility

The ethanol level is useful in emergency medicine for:

  • Correlating intoxication findings with an objective level
  • Identifying when clinical presentation is worse than expected for the level (look for other causes)
  • Calculating osmol gap to evaluate for toxic alcohols
  • Predicting time to sobriety for disposition planning
  • Medicolegal documentation
Serum vs. Whole Blood: Serum ethanol levels are approximately 10-15% higher than whole blood levels due to the higher water content of serum. Legal blood alcohol content (BAC) is based on whole blood.
Quick Reference
  • Legal Limit (US): 80 mg/dL (0.08% BAC)
  • Clinical Intoxication: Varies widely with tolerance
  • Life-Threatening: >300 mg/dL in non-tolerant individuals
  • Lethal Range: >400 mg/dL (though chronic drinkers may survive much higher)
  • Elimination Rate: 15-25 mg/dL/hour (zero-order kinetics)
  • Osmol Gap Contribution: Ethanol (mg/dL) / 4.6 = contribution to osmol gap
  • Key Point: If the clinical picture is not explained by the ethanol level, look for co-ingestions, traumatic brain injury, or metabolic derangements
Clinical Correlation by Level

Note: These correlations apply to non-tolerant individuals. Chronic heavy drinkers may appear minimally impaired at levels that would be life-threatening in naive individuals.

Swipe to see more
Level (mg/dL) BAC (%) Expected Effects (Non-Tolerant)
20-50 0.02-0.05 Relaxation, mild euphoria, decreased inhibition
50-100 0.05-0.10 Impaired coordination, judgment, and reaction time
100-200 0.10-0.20 Ataxia, slurred speech, nausea, emotional lability
200-300 0.20-0.30 Drowsiness, vomiting, hypothermia, confusion
300-400 0.30-0.40 Stupor, respiratory depression, aspiration risk
>400 >0.40 Coma, respiratory failure, death
Tolerance is extreme and unpredictable. Chronic alcoholics may walk and talk at levels exceeding 400 mg/dL. Conversely, a non-tolerant adolescent may develop respiratory arrest at 200-300 mg/dL. Never use the ethanol level alone to determine clinical management — always assess the patient.
Clinical Significance

Osmol Gap and Toxic Alcohol Evaluation

Ethanol contributes to the serum osmolality. The contribution can be calculated:

  • Ethanol contribution to osmolality: Ethanol (mg/dL) / 4.6
  • When calculating osmol gap to evaluate for toxic alcohols (methanol, ethylene glycol), you must account for ethanol's contribution
  • An elevated osmol gap AFTER accounting for ethanol suggests presence of another osmotically active substance

Alcohol-Related Metabolic Derangements

  • Hypoglycemia: Ethanol inhibits gluconeogenesis; particularly dangerous in children, malnourished patients, and those with depleted glycogen stores
  • Lactic acidosis: NADH/NAD+ ratio increases, favoring lactate production
  • Ketoacidosis: Alcoholic ketoacidosis (AKA) — occurs during fasting/vomiting after a binge; beta-hydroxybutyrate predominates (standard ketone tests may be negative)
  • Hypomagnesemia: Ethanol promotes renal magnesium wasting
  • Hypokalemia: From vomiting, poor intake, and renal losses
  • Hypophosphatemia: Especially during refeeding after prolonged alcohol use

Alcohol Withdrawal

Withdrawal symptoms can begin while the patient still has a measurable ethanol level (as the level falls):

  • 6-24 hours: Tremor, anxiety, diaphoresis, tachycardia, insomnia
  • 12-48 hours: Withdrawal seizures (typically generalized tonic-clonic)
  • 12-48 hours: Alcoholic hallucinosis (visual, auditory, tactile)
  • 48-96 hours: Delirium tremens (DTs) — confusion, agitation, autonomic instability, fever; mortality 5-15% if untreated
Interpretation Guidelines

When Clinical Picture Does Not Match the Level

If the patient appears more impaired than expected for the measured ethanol level, consider:

  • Co-ingestion: Benzodiazepines, opioids, barbiturates, other sedatives
  • Head trauma: Intracranial hemorrhage (subdural, epidural, subarachnoid)
  • Hypoglycemia: Check point-of-care glucose on every intoxicated patient
  • Toxic alcohols: Methanol, ethylene glycol, isopropanol
  • Postictal state: Withdrawal seizure, or other cause
  • Infection: Meningitis, encephalitis, sepsis
  • Hepatic encephalopathy: In patients with chronic liver disease
  • Wernicke encephalopathy: Thiamine deficiency — triad of confusion, ataxia, ophthalmoplegia

Estimating Time to Sobriety

Using zero-order elimination kinetics:

  • Average elimination rate: 20 mg/dL/hour
  • Time to zero = Current level / 20
  • Example: Patient with level of 200 mg/dL → approximately 10 hours to reach zero
Always check a glucose on intoxicated patients. Ethanol inhibits gluconeogenesis, and hypoglycemia can mimic or exacerbate intoxication. This is especially critical in children, who have limited glycogen stores and can develop life-threatening hypoglycemia from small alcohol exposures.
Interfering Factors

Factors That May Cause Falsely Elevated Levels

  • Isopropanol contamination: If the skin is cleaned with isopropyl alcohol before venipuncture (use chlorhexidine or povidone-iodine instead)
  • Lactate-containing specimens: Some enzymatic assays may cross-react
  • Elevated LDH or lactate: Can interfere with some enzymatic methods

Important Sampling Considerations

  • Use non-alcohol containing antiseptic for phlebotomy site
  • Gray-top (fluoride-oxalate) tube prevents in-vitro fermentation (important for forensic samples)
  • In-vitro production of ethanol can occur in specimens with high glucose levels and bacterial contamination

Auto-Brewery Syndrome

Rare condition where gut flora (typically Candida species) ferment carbohydrates into ethanol endogenously. Patients may have measurable ethanol levels without exogenous alcohol consumption. Consider in patients with unexplained, recurrent elevated ethanol levels.

Clinical Pearls
"Drunk until proven otherwise" is dangerous thinking: Never attribute altered mental status solely to alcohol intoxication without ruling out hypoglycemia, head injury, co-ingestions, and other medical emergencies. Perform a thorough exam including a complete neuro check.
Give thiamine before dextrose (or simultaneously): In chronic alcoholics, dextrose administration without thiamine can precipitate or worsen Wernicke encephalopathy. Give 100-500 mg IV thiamine to all chronic alcohol users.
The "gap" between clinical and measured: If a patient appears minimally intoxicated but has a very high ethanol level, they have significant tolerance and are at high risk for severe withdrawal. Plan accordingly.
Pediatric alcohol exposure is an emergency. Children (especially <5 years) are at extreme risk of hypoglycemia from alcohol exposure. Even small amounts from hand sanitizer, mouthwash, or cooking extracts can cause dangerous levels. Manage aggressively with glucose monitoring and IV dextrose.
Isopropanol (rubbing alcohol): Metabolized to acetone (not an acid) — causes elevated osmol gap WITHOUT anion gap acidosis. Unlike methanol/ethylene glycol, isopropanol poisoning does not produce an anion gap metabolic acidosis. Ketones will be positive (acetone).
Alcohol + trauma = CT the head: Intoxicated patients have a significantly higher rate of intracranial hemorrhage, particularly subdural hematoma, due to both increased fall risk and coagulopathy. Maintain a very low threshold for head imaging.
References
  1. Mchugh, R. K., & Weiss, R. D. (2019). Alcohol use disorder. New England Journal of Medicine, 380(15), 1443-1455.
  2. Kraut, J. A., & Kurtz, I. (2008). Toxic alcohol ingestions: clinical features, diagnosis, and management. Clinical Journal of the American Society of Nephrology, 3(1), 208-225.
  3. Farkas, Josh MD. (2015). Alcohol-related emergencies. EMCrit Project — Internet Book of Critical Care.
  4. Nickson, C. (n.d.). Ethanol toxicity. Life in the Fast Lane (LITFL).
  5. Hoffman, R. S., et al. (2014). Goldfrank's Toxicologic Emergencies, 10th ed. McGraw-Hill.
Back to Toxicology Panel All Lab Values
Medical Disclaimer
  • For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
  • Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
  • Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.
AI Assistance Notice
The clinical content and references are curated and reviewed by myself; however, AI was used to assist in organizing, paraphrasing, and formatting the information presented.